EXAS - Exact Sciences Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Exact Sciences Corporation

441 Charmany Drive
Madison, WI 53719
United States
608-284-5700
http://www.exactsciences.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees1,268

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin T. ConroyChairman, Pres & CEO1.22M12.02M1966
Mr. Jeffrey T. Elliott CFACFO & Chief Accounting Officer422.44kN/A1978
Mr. Graham P. LidgardChief Science Officer634.31k5.31M1949
Mr. D. Scott CowardChief Legal Officer, Sr. VP, Gen. Counsel & Sec.628.65kN/A1965
Mr. Maneesh K. AroraTransition Consultant863.38k12.36M1969
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

Corporate Governance

Exact Sciences Corporation’s ISS Governance QualityScore as of June 1, 2018 is 7. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 10; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.